AI assistant
Sending…
Adicet Bio, Inc. — Director's Dealing 2021
Jun 14, 2021
34412_dirs_2021-06-14_a4aa45dc-cf01-424d-bca6-9b42927ba6db.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2021-06-11
Reporting Person: ABBOT STEWART (See Remarks)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-11 | Non-Qualified Option (right to buy) | $11.75 | A | 5000 | Acquired | 2031-06-10 | Common Stock (5000) | Direct |
Footnotes
F1: The shares underlying this option shall vest in twelve equal monthly installments commencing on June 11, 2021.
More from Adicet Bio, Inc.
Annual Report
2026
May 20
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Mar 24
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Jan 27
Director's Dealing
2026
Jan 27